Inhibitory antibodies against ADAMTS13 have been reported in 44-93% of TTP patients;9 and among our 9 tested patient inhibitor was detected in 6 (66.6%) patients with a titer range of 0.425 BU. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.